Dan Peer
Dan Peer
Prof. of NanoMedicine and Immunology, Tel Aviv University
Dirección de correo verificada de post.tau.ac.il
Citado por
Citado por
Nanocarriers as an emerging platform for cancer therapy
D Peer, JM Karp, S Hong, OC Farokhzad, R Margalit, R Langer
Nature nanotechnology 2 (12), 751-760, 2007
Progress and challenges towards targeted delivery of cancer therapeutics
D Rosenblum, N Joshi, W Tao, JM Karp, D Peer
Nature communications 9 (1), 1-12, 2018
Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target
D Peer, EJ Park, Y Morishita, CV Carman, M Shimaoka
Science 319 (5863), 627-630, 2008
Nanoparticle hydrophobicity dictates immune response
DF Moyano, M Goldsmith, DJ Solfiell, D Landesman-Milo, OR Miranda, ...
Journal of the American Chemical Society 134 (9), 3965-3967, 2012
Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1
D Peer, P Zhu, CV Carman, J Lieberman, M Shimaoka
Proceedings of the National Academy of Sciences 104 (10), 4095-4100, 2007
Polysaccharides as building blocks for nanotherapeutics
S Mizrahy, D Peer
Chemical Society Reviews 41 (7), 2623-2640, 2012
The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation
R Kedmi, N Ben-Arie, D Peer
Biomaterials 31 (26), 6867-6875, 2010
Loading mitomycin C inside long circulating hyaluronan targeted nano‐liposomes increases its antitumor activity in three mice tumor models
D Peer, R Margalit
International Journal of Cancer 108 (5), 780-789, 2004
Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal doxorubicin in syngeneic and human xenograft mouse tumor models
D Peer, R Margalit
Neoplasia (New York, NY) 6 (4), 343, 2004
Nanoparticles for imaging, sensing, and therapeutic intervention
LK Bogart, G Pourroy, CJ Murphy, V Puntes, T Pellegrino, D Rosenblum, ...
ACS nano 8 (4), 3107-3122, 2014
RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice
SS Kim, D Peer, P Kumar, S Subramanya, H Wu, D Asthana, K Habiro, ...
Molecular therapy 18 (2), 370-376, 2010
Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response
S Mizrahy, SR Raz, M Hasgaard, H Liu, N Soffer-Tsur, K Cohen, R Dvash, ...
Journal of controlled release 156 (2), 231-238, 2011
Mechanisms and barriers in cancer nanomedicine: addressing challenges, looking for solutions
TJ Anchordoquy, Y Barenholz, D Boraschi, M Chorny, P Decuzzi, ...
ACS nano 11 (1), 12-18, 2017
RNAi-based nanomedicines for targeted personalized therapy
A Daka, D Peer
Advanced drug delivery reviews 64 (13), 1508-1521, 2012
Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors
I Rivkin, K Cohen, J Koffler, D Melikhov, D Peer, R Margalit
Biomaterials 31 (27), 7106-7114, 2010
Special delivery: targeted therapy with small RNAs
D Peer, J Lieberman
Gene therapy 18 (12), 1127-1133, 2011
Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles
ZR Cohen, S Ramishetti, N Peshes-Yaloz, M Goldsmith, A Wohl, Z Zibly, ...
ACS nano 9 (2), 1581-1591, 2015
Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models
D Peer, Y Dekel, D Melikhov, R Margalit
Cancer Research 64 (20), 7562-7569, 2004
Hyaluronan is a key component in cryoprotection and formulation of targeted unilamellar liposomes
D Peer, A Florentin, R Margalit
Biochimica et Biophysica Acta (BBA)-Biomembranes 1612 (1), 76-82, 2003
Corneal gene therapy
EA Klausner, D Peer, RL Chapman, RF Multack, SV Andurkar
Journal of Controlled Release 124 (3), 107-133, 2007
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20